Quick Overview: In this session, Dr Samuel Urrutia discusses relevant updates in the myelodysplastic and myeloproliferative neoplasms. In this session, Dr Steven Bair discusses targeted treatment pathways in chronic myeloid leukemia. Leading cancer researchers gathered in San Antonio for the Practical Applications of New Agents in Oncology (PANAO) ...
Hematology Conference 2026 - Detailed Overview & Context
In this session, Dr Samuel Urrutia discusses relevant updates in the myelodysplastic and myeloproliferative neoplasms. In this session, Dr Steven Bair discusses targeted treatment pathways in chronic myeloid leukemia. Leading cancer researchers gathered in San Antonio for the Practical Applications of New Agents in Oncology (PANAO) ... This session was recorded during the Cholangiocarcinoma Foundation Annual Welcome to Session 1 of the Haematological Malignancy Diagnostic Service (HMDS) Network ASH Clinical News Editor-in-Chief Bethany Samuelson Bannow, MD, MCR, previews the forthcoming March
Case Presentation: “Misattributed HLH: A Diagnostic Odyssey” Presenter: Sonia Iosim, MD Mentor: Sarah Chamseddine, MD ... Constantine Mitsiades, MD, PhD, provides an update on the ongoing advances in multiple myeloma research toward safer and ... Shahrier Hossain, PharmD, BCOP, and Tina Flaherty, MS, ANP-BC, AOCN, provide details on how patients with multiple myeloma ... Join Elissa Baldwin from the Blood Cancer United Patient Education team as she brings you inside the 2025 American Society of ... In this session, Dr Ajay Major moderates an extended panel discussion on “game-changing” results from 2025 and their impact on ... Welcome to Session 3 of the Haematological Malignancy Diagnostic Service (HMDS) Network
Dr. Jae Park, Chief, Cellular Therapy Service, ALL Specialist, and Professor of Medicine at Memorial Sloan Kettering Cancer ...
